ENTITY
Aurobindo Pharma

Aurobindo Pharma (ARBP IN)

160
Analysis
Health Care • India
Aurobindo Pharma is an Indian multinational pharmaceutical manufacturing company that develops, manufactures, and commercializes a wide range of generic pharmaceuticals, active pharmaceutical ingredients (APIs), and specialty formulations. The company's product portfolio covers therapeutic areas including antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterologicals, anti-allergics, oncology, and dermatology. It commenced operations in 1988-1989 with a single unit manufacturing semi-synthetic penicillin in Puducherry. Headquartered in Hyderabad, Telangana, India, the company was founded in 1986.
more
•14 May 2025 19:34•Broker

Pharmaceuticals: US to cut Rx drug price, no impact on generics

The US president Donald Trump signed an “Executive Order” (EO) to bring the prices for prescription (Rx) drugs in line with other developed nations

Logo
216 Views
Share
•04 Apr 2025 05:28•Broker

Pharmaceuticals: Pharma dodges first round of US tariff risk

The US government under Trump 2.0 has announced reciprocal tariffs across countries, including ~26% tariff on imports from India

Logo
261 Views
Share
•15 Jan 2025 21:37•Broker

Pharma and Healthcare (Q3FY25E): Growth Momentum, Margin Visibility Stay Intact

The India Pharma & Healthcare sector is expected to see steady growth in Q3FY25E. We project sales/EBITDA growth of 11%/13% YoY for our coverage...

Logo
361 Views
Share
•03 Dec 2024 07:42•Broker

Axis Top Picks for the Month of December 2024

Axis Top Picks Basket delivered a return of 10.9% in the last six months against the 7.1% returns posted by Nifty 50 over the same period.

Logo
505 Views
Share
•13 Nov 2024 09:13•Broker

HSIE Results Daily: Shree Cement, Aurobindo Pharma, Gujarat State Petronet

During Q2FY25, Shree volume declined 7% YoY as it focused on trade sales while non-trade demand was weak. Cement NSR fell only 0.4% QoQ, lower vs...

Logo
343 Views
Share
x